Filing Details
- Accession Number:
- 0001127602-14-016568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-06 16:08:52
- Reporting Period:
- 2014-05-05
- Filing Date:
- 2014-05-06
- Accepted Time:
- 2014-05-06 15:08:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1141720 | F Thomas Ackerman | 251 Ballardvale Street Wilmington MA 01887 | Corp. Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-05-05 | 200 | $51.35 | 104,511 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-05-05 | 200 | $51.36 | 104,311 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-05-05 | 100 | $51.37 | 104,211 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This sale occured pursuant to a 10b5-1 Trading Plan.